A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.

This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...

Cancer is often perceived as a fate, but what if it could be avoided even before it manifests? Scientists have just taken a significant step in that direction. Their work on mice reveals that ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...